FIELD: medicine.
SUBSTANCE: diagnostic technique for amyloidosis accompanying Alzheimer's disease consists in determining the difference of nano β-amyloid Aβ (1-42) and/or Aβ (1-40) monomer counts in test and reference aliquots of a blood plasma sample with the oligomer formations being dissociated to nano β-amyloid Aβ (1-42) and/or Aβ (1-40) monomers in the test aliquot by exposing the aliquot to ultrasound under certain condition.
EFFECT: use of the declared technique enables higher sensitivity of diagnosing amyloidosis accompanying Alzheimer's disease.
2 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF AMYLOIDOSIS DIAGNOSTICS IN PATIENTS WITH ALZHEIMERTS DISEASE AND SET OF MEANS FOR ITS REALISATION | 2006 |
|
RU2356058C2 |
| USING ANTI-AMYLOID BETA ANTIBODY IN OPHTHALMIC DISEASES | 2008 |
|
RU2604181C2 |
| PEPTIDE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | 2018 |
|
RU2679080C1 |
| PEPTIDE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | 2018 |
|
RU2679059C1 |
| MONOCLONAL BODY AGAINST AMYLOID BETA | 2008 |
|
RU2571856C2 |
| HUMANISED ANTIBODY | 2008 |
|
RU2538709C2 |
| APPLICATION OF ANTIBODY AGAINST AMYLOID-BETA IN CASE OF EYE DISEASES | 2008 |
|
RU2571859C2 |
| METHOD FOR IN VITRO DIAGNOSIS OF ALZHEIMER'S DISEASE USING MONOCLONAL ANTIBODY | 2006 |
|
RU2416619C2 |
| HUMANISED ANTIBODIES TO β-AMYLOID PEPTIDE | 2008 |
|
RU2475500C2 |
| HUMANISED ANTIBODY TO BETA AMYLOID | 2007 |
|
RU2498999C2 |
